References

The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study

10.1136/annrheumdis-2013-204627 · 2014 · External reference

Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis

10.1016/j.berh.2018.10.005 · 2018 · External reference

Rheumatoid arthritis - common origins, divergent mechanisms

10.1056/nejmra2103726 · 2023 · External reference

Novel treatment strategies in rheumatoid arthritis

10.1016/s0140-6736(17)31491-5 · 2017 · External reference

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

10.1136/ard-2023-224476 · 2023 · External reference

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

10.1503/cmaj.091391 · 2009 · External reference

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years

10.1038/s41598-021-94504-x · 2021 · External reference

Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review

10.1016/j.ejmech.2018.09.027 · 2018 · External reference

Mendelian randomization in cardiometabolic disease: challenges in evaluating causality

10.1038/nrcardio.2017.78 · 2017 · External reference

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

10.1093/hmg/ddu328 · 2014 · External reference

Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement

10.1001/jama.2021.18236 · 2021 · External reference

FinnGen provides genetic insights from a well-phenotyped isolated population

10.1038/s41586-022-05473-8 · 2023 · External reference

Plasma proteomic associations with genetics and health in the UK Biobank

10.1038/s41586-023-06592-6 · 2023 · External reference

Large-scale integration of the plasma proteome with genetics and disease

10.1038/s41588-021-00978-w · 2021 · External reference

Genetics of rheumatoid arthritis contributes to biology and drug discovery

10.1038/nature12873 · 2014 · External reference

Common genetic associations between age-related diseases

10.1038/s43587-021-00051-5 · 2021 · External reference

Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator

10.1002/gepi.21965 · 2016 · External reference

Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression

10.1093/ije/dyv080 · 2015 · External reference

False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies

10.1016/j.jclinepi.2014.03.012 · 2014 · External reference

Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses

10.1016/j.xcrm.2023.101174 · 2023 · External reference

SRplot: A free online platform for data visualization and graphing

10.1371/journal.pone.0294236 · 2023 · External reference

The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest

10.1093/nar/gkac1000 · 2023 · External reference

Reflux esophagitis and its role in the pathogenesis of Barrett’s metaplasia

10.1007/s00535-017-1342-1 · 2017 · External reference

Integrative genomic deconvolution of rheumatoid arthritis GWAS loci into gene and cell type associations

10.1186/s13059-016-0948-6 · 2016 · External reference

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission

10.1038/s41467-018-05044-4 · 2018 · External reference

Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs

10.1038/s41598-023-36999-0 · 2023 · External reference

Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients

10.1371/journal.pone.0006803 · 2009 · External reference

Heterogeneity of synovial molecular patterns in patients with arthritis

10.1371/journal.pone.0122104 · 2015 · External reference

Disease-Regulated Gene Therapy with Anti-Inflammatory Interleukin-10 Under the Control of the CXCL10 Promoter for the Treatment of Rheumatoid Arthritis

10.1089/hum.2015.127 · 2016 · External reference

CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 and Wnt signaling pathways in rheumatoid arthritis: evidence from a case-control study

10.1186/s13075-015-0590-9 · 2015 · External reference

Rank-in: enabling integrative analysis across microarray and RNA-seq for cancer

10.1093/nar/gkab554 · 2021 · External reference

pROC: an open-source package for R and S+ to analyze and compare ROC curves

10.1186/1471-2105-12-77 · 2011 · External reference

Basic principles of ROC analysis

10.1016/s0001-2998(78)80014-2 · 1978 · External reference

Use of ROC curves in clinical and experimental studies

2020 · External reference

Novel Linear Peptides with High Affinity to αvβ3 Integrin for Precise Tumor Identification

10.7150/thno.18401 · 2017 · External reference

DSigDB: drug signatures database for gene set analysis

10.1093/bioinformatics/btv313 · 2015 · External reference

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

10.1093/nar/gkw377 · 2016 · External reference

PubChem 2023 update

2022 · External reference

RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning

10.1093/nar/gkac1077 · 2023 · External reference

AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences

10.1093/nar/gkad1011 · 2024 · External reference

AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models

10.1093/nar/gkab1061 · 2022 · External reference

CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting

2022 · External reference

Ligand docking and binding site analysis with PyMOL and Autodock/Vina

10.1007/s10822-010-9352-6 · 2010 · External reference

Shu-Xie decoction alleviates oxidative stress and colon injury in acute sleep-deprived mice by suppressing p62/KEAP1/NRF2/HO1/NQO1 signaling

10.3389/fphar.2023.1107507 · 2023 · External reference

Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers

10.3389/fimmu.2024.1394438 · 2024 · External reference

Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3

10.1016/j.biomaterials.2013.10.072 · 2014 · External reference

GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation

10.1021/ct700301q · 2008 · External reference

CHARMM36m: an improved force field for folded and intrinsically disordered proteins

10.1038/nmeth.4067 · 2017 · External reference

Strain fluctuations and elastic constants

10.1063/1.443248 · 1982 · External reference

Molecular dynamics with coupling to an external bath

10.1063/1.448118 · 1984 · External reference

L. donovani XPRT: Molecular characterization and evaluation of inhibitors

10.1016/j.bbapap.2017.12.002 · 2018 · External reference

Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway

10.3892/mmr.2023.12940 · 2023 · External reference

E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes

10.3389/fimmu.2024.1433898 · 2024 · External reference

The role of interleukin-17 in the pathogenesis of rheumatoid arthritis

10.1007/s11926-009-0052-y · 2009 · External reference

NF-κB Signaling Pathway in Rheumatoid Arthritis: Mechanisms and Therapeutic Potential

10.1007/s12035-024-04634-2 · 2025 · External reference

Regulation of TNF-α with a focus on rheumatoid arthritis

10.1038/icb.2013.15 · 2013 · External reference

FCRL3 gene polymorphisms as risk factors for rheumatoid arthritis

10.1016/j.humimm.2015.12.007 · 2016 · External reference

Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis

10.1007/s00296-009-1082-5 · 2010 · External reference

FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians

10.1136/ard.2006.064949 · 2007 · External reference

Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population

10.1002/art.22270 · 2006 · External reference

Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association

10.1210/jc.2006-2183 · 2007 · External reference

Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis

10.1136/ard.2005.048454 · 2006 · External reference

Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis

10.1038/nrrheum.2010.23 · 2010 · External reference

Genetics of rheumatoid arthritis: underlying evidence of ethnic differences

10.1016/j.jaut.2009.02.020 · 2009 · External reference

The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases

10.1136/ard.2007.077826 · 2008 · External reference

Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population

10.1038/gene.2011.30 · 2011 · External reference

CD4 and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in patients with untreated early arthritis: implications for causal gene identification

10.1002/art.40393 · 2018 · External reference

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology

10.1016/j.it.2009.05.007 · 2009 · External reference

A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis

10.1038/ng.874 · 2011 · External reference

Novel gene therapy for rheumatoid arthritis with single local injection: adeno-associated virus-mediated delivery of A20/TNFAIP3

2022 · External reference

A20 controls RANK-dependent osteoclast formation and bone physiology

10.15252/embr.202255233 · 2022 · External reference

Common variants at CD40 and other loci confer risk of rheumatoid arthritis

10.1038/ng.233 · 2008 · External reference

Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients

10.1136/annrheumdis-2011-201225 · 2012 · External reference

Associations between TNFAIP3 Polymorphisms and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Update with Trial Sequential Analysis

2022 · External reference

Functional genomics atlas of synovial fibroblasts defining rheumatoid arthritis heritability

10.1186/s13059-021-02460-6 · 2021 · External reference

Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis

10.1074/jbc.m111.248039 · 2011 · External reference

Differences in biomarkers of cartilage matrix turnover and their changes over 2 years in adolescent and adult volleyball athletes

10.1186/s40634-017-0081-9 · 2017 · External reference

Association between changes in molecular biomarkers of cartilage matrix turnover and changes in knee articular cartilage: a longitudinal pilot study

10.1186/s40634-019-0179-3 · 2019 · External reference

Expression of CILP-2 and DDR2 and ultrastructural changes in the articular cartilage of patients with knee osteoarthritis undergoing total knee arthroplasty: a pilot morphological study

10.1007/s00795-022-00339-4 · 2023 · External reference

ERK1/2 activation induced by inflammatory cytokines compromises effective host tissue integration of engineered cartilage

10.1089/ten.tea.2008.0663 · 2009 · External reference

Hapln4/Bral2 is a selective regulator for formation and transmission of GABAergic synapses between Purkinje and deep cerebellar nuclei neurons

10.1111/jnc.14571 · 2018 · External reference

Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area

10.1016/j.biopsych.2010.07.035 · 2011 · External reference

Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders

10.1093/schbul/sbad100 · 2023 · External reference

Linking epileptic phenotypes and neural extracellular matrix remodeling signatures in mouse models of epilepsy

10.1016/j.nbd.2023.106324 · 2023 · External reference

Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I

10.1016/j.ymgme.2014.09.012 · 2015 · External reference

EHBP1 SNPs, Their Haplotypes, and Gene-Environment Interactive Effects on Serum Lipid Levels

10.1021/acsomega.9b03522 · 2020 · External reference

SUGP1 is a novel regulator of cholesterol metabolism

2016 · External reference

Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study

10.1186/s12967-023-04474-z · 2023 · External reference

A large-scale genetic correlation scan between rheumatoid arthritis and human plasma protein

10.1302/2046-3758.112.bjr-2021-0270.r1 · 2022 · External reference